How Pharma Cos. Can Evaluate Alliance Agreements' Validity
In 2013, the U.S. Supreme Court issued a landmark decision regarding antitrust reverse payments in Federal Trade Commission v. Actavis.[1] The court's decision was followed by a surge of more than 25...To view the full article, register now.
Already a subscriber? Click here to view full article